Cargando…
Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola
BACKGROUND: Drug resistance in Plasmodiumfalciparum has posed an obstacle to effective treatment and challenges many malaria control programmes in endemic areas. In Angola, until 2003, chloroquine (CQ) was used as first-line therapy for uncomplicated malaria. It was replaced initially by amodiaquine...
Autores principales: | Kiaco, Kinanga, Teixeira, Joana, Machado, Marta, do Rosário, Virgílio, Lopes, Dinora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681156/ https://www.ncbi.nlm.nih.gov/pubmed/26670642 http://dx.doi.org/10.1186/s12936-015-1018-3 |
Ejemplares similares
-
The drug transporter ABCB1 c.3435C>T SNP influences artemether–lumefantrine treatment outcome
por: Kiaco, Kinanga, et al.
Publicado: (2017) -
Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola
por: Figueiredo, Paula, et al.
Publicado: (2008) -
Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019
por: Dimbu, Pedro Rafael, et al.
Publicado: (2021) -
Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique
por: Silva-Pinto, André, et al.
Publicado: (2021) -
Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
por: Plucinski, Mateusz M., et al.
Publicado: (2017)